| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/10/2002 | US20020004242 Plasmids for construction of eukaryotic viral vectors |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170363A1 Virus envelope vector for gene transfer |
| 01/09/2002 | EP1169480A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
| 01/09/2002 | EP1169473A1 High sensitivity phage display biomolecule detection |
| 01/09/2002 | EP1169464A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1 |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169452A1 Viral variants |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169341A1 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 01/09/2002 | EP1169063A2 Treatment of intracellular infection |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330715A Selectively replicating viral vectors |
| 01/09/2002 | CN1330712A Biogical compositions, components thereof and uses therefor |
| 01/08/2002 | US6337317 Amino acid sequence peptides as microbiocides |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337088 Selecting a bacteriophage having dimensions similar to virus; loading bacteriophage into jacket comprising hollow fiber, sealing top and bottom ends, placing jacket into bath solution, inoculating lawn of bacteria, calculating retention |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 01/03/2002 | WO2002000883A2 Rescue of canine distemper virus from cdna |
| 01/03/2002 | WO2002000881A1 Bvdv virus-like particles |
| 01/03/2002 | WO2002000868A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | WO2002000694A2 Modified morbillivirus v proteins |
| 01/03/2002 | WO2002000693A2 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/03/2002 | WO2002000687A2 Antimicrobial peptides and methods of use thereof |
| 01/03/2002 | WO2002000266A2 A method of treating and preventing infectious diseases |
| 01/03/2002 | WO2001075097A3 Improvements to ribosome display |
| 01/03/2002 | WO2001048155A3 Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants |
| 01/03/2002 | US20020002143 AIDS virus vaccines using sendai virus vector |
| 01/03/2002 | US20020001595 Sampling antigen-containing blood and/or tissue; obtaining liquid/homogenate; adding crosslinking agent; heating to solidification; mixing with pyrogen-free salt solution; for treatment of AIDS, HIV |
| 01/03/2002 | US20020001590 Antibacterial therapy for multi-drug resistant bacteria |
| 01/03/2002 | CA2413800A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | CA2413786A1 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/03/2002 | CA2412637A1 Replication deficient adenoviral tnf vector |
| 01/03/2002 | CA2412621A1 Rescue of canine distemper virus from cdna |
| 01/03/2002 | CA2412503A1 A method of treating and preventing infectious diseases |
| 01/02/2002 | EP1167530A2 PVX capsid-antigen fusion protein, chimaeric viral particles displaying it on the capsid, plants infected with said particles, their uses and compositions comprising them |
| 01/02/2002 | EP1166797A1 Method of controlling the qualities of attenuated pox vaccine |
| 01/02/2002 | EP1166775A2 Targeted liposome gene delivery |
| 01/02/2002 | EP1165842A1 Lentiviral vector system for high quantity screening |
| 01/02/2002 | EP1165817A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration |
| 01/02/2002 | EP1165816A2 Insect viral vectors and uses thereof |
| 01/02/2002 | EP1165815A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 01/02/2002 | EP1165810A2 Transducing phages |
| 01/02/2002 | EP1165798A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/02/2002 | EP1165793A2 Cyclin dependent kinase inhibitor genes from plants |
| 01/02/2002 | EP1165773A1 Advanced antigen presentation platform |
| 01/02/2002 | EP1165756A2 Adaptation of virus to vertebrate cells |
| 01/02/2002 | EP1165131A2 Attenuated dengue-1 virus vaccine |
| 01/02/2002 | EP1165130A2 Attenuated dengue-3 virus vaccine |
| 01/02/2002 | EP1165129A1 Attenuated dengue-4 virus vaccine |
| 01/02/2002 | EP1165128A2 Attenuated dengue-2 virus vaccine |
| 01/02/2002 | EP1165127A2 Multivalent dengue virus vaccine |
| 01/01/2002 | US6335185 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 01/01/2002 | US6335160 Methods and compositions for polypeptide engineering |
| 01/01/2002 | US6335016 Chicken embryo lethal orphan (CELO) virus |
| 01/01/2002 | US6335011 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease |
| 01/01/2002 | US6335009 Enhancing sensitivity of cancer tumor cell to dna damaging agent or irradiation by delivering promoter linked to a poly (adp-ribose)-polymerase encoding polynucleotide |
| 01/01/2002 | CA1341331C Viral vector and recombinant dna coding for one or more structural protein (ha, f and/or np) of a morbillivirus, infected cell culture, resulting proteins, vaccine and antibodies |
| 12/27/2001 | WO2001098514A2 Targeting viral vectors to specific cells |
| 12/27/2001 | WO2001098507A1 Chimeric hsf transcription factors |
| 12/27/2001 | WO2001097840A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 12/27/2001 | WO2001097839A1 Recombinant vaccines against infectious bursal disease virus |
| 12/27/2001 | WO2001055353A3 Recombinant attenuation of prrsv |
| 12/27/2001 | WO2001053505A3 Herpes virus strains for gene therapy |
| 12/27/2001 | WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity |
| 12/27/2001 | WO2001040443A3 Method for producing adherent animal cells |
| 12/27/2001 | US20010055791 Methods for enhancing the production of interferon in cell culture |
| 12/27/2001 | US20010055755 Dendritic marker-expressing macrophage cultures and methods for reactivating latent HCMV |
| 12/27/2001 | CA2411945A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
| 12/20/2001 | WO2001096610A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001095933A2 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | WO2001050872A3 Method for produce sanitation using bacteriophages |
| 12/20/2001 | WO2001046390A3 Method of inactivating microorganisms |
| 12/20/2001 | US20010053367 Vaccines expressed in plants |
| 12/20/2001 | US20010053352 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 12/20/2001 | CA2412343A1 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | CA2412217A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
| 12/19/2001 | EP1163522A1 Method for detecting superantigen activity in a biological sample |
| 12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
| 12/19/2001 | EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors |
| 12/19/2001 | EP1163354A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 12/19/2001 | EP0979093B1 Arrestable therapeutic viral agent |
| 12/19/2001 | EP0746624B1 Vector for liver-specific gene expression |
| 12/19/2001 | EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 12/13/2001 | WO2001094560A2 In vitro assembly of sv40 viruses and pseudoviruses |
| 12/13/2001 | WO2001093901A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | WO2001046408A3 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 12/13/2001 | WO2001032852A3 Method for directed packaging of molecular substances in protein shells |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | US20010051161 Cold-adapted equine influenza viruses |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/12/2001 | EP1162273A1 Recombinant DNA vectors for gene therapy |